Ana Djukovic

Ana Djukovic

Auto-generated profile, based on publicly available information

Ana Djukovic

Microbiome Mechanisms in Health and Disease Laboratory, Centro de Investigación Príncipe Felipe, Valencia, Spain

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2024 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
CLChen Liao
Chen Liao
TRThierry Rolling
Thierry Rolling
ADAna Djukovic
Ana Djukovic
TFTeng Fei
Teng Fei
VMVishwas Mishra
Vishwas Mishra
JXJoao B. Xavier
Joao B. Xavier

24 September 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
ADAna Djukovic
Ana Djukovic
MGMaría José Garzón
María José Garzón
CCCécile Canlet
Cécile Canlet
VCVitor Cabral
Vitor Cabral
RLRym Lalaoui
Rym Lalaoui
CÚCarles Úbeda
Carles Úbeda
Infections by multidrug-resistantEnterobacteriaceae(MRE) are life-threatening to patients. The intestinal microbiome protects against MRE colonization, but antibiotics cause collateral damage to commensals and open the way to colonization and subsequent infection. Despite the significance of this problem, the specific commensals and mechanisms that restrict MRE colonization remain largely unknown. Here, by performing a multi-omic prospective study of hospitalized patients combined with mice experiments, we find thatLactobacillusis key, though not sufficient, to restrict MRE gut colonization.Lactobacillus rhamnosusandmurinusincrease the levels of Clostridiales bacteria, which induces a hostile environment for MRE growth through increased butyrate levels and reduced nutrient sources. This mechanism of colonization resistance, an interaction betweenLactobacillusspp. and Clostridiales involving cooperation between microbiota members, is conserved in mice and patients. These results stress the importance of exploiting microbiome interactions for developing effective probiotics that prevent infections in hospitalized patients.

16 June 2023 in Cell Host & Microbe
Verified
Journal Article
Closed access
JSJonas Schluter
Jonas Schluter
ADAna Djukovic
Ana Djukovic
BTBradford P. Taylor
Bradford P. Taylor
JYJinyuan Yan
Jinyuan Yan
CDCaichen Duan
Caichen Duan
JXJoao B. Xavier
Joao B. Xavier

10 May 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
ADAna Djukovic
Ana Djukovic
CLChen Liao
Chen Liao
ABAndras Bimbo-Szuhai
Andras Bimbo-Szuhai
CLChloe Lindberg
Chloe Lindberg
HLHui Liu
Hui Liu
JXJoao B. Xavier
Joao B. Xavier
SUMMARY: The kynurenine pathway (KP) of tryptophan metabolism shapes host immunity and is implicated in inflammatory, malignant, and neurodegenerative diseases. Although it is well known that inflammation influences KP activity, whether and how gut microbiota regulates KP in the intestine remains unclear. Here, we find that in allogeneic hematopoietic cell transplant patients, the kynurenine-to-tryptophan ratio tracks plasma neopterin, whereas intestinal levels do not, suggesting that local KP regulation is not explained by inflammation alone. In mice, targeted microbiota perturbation downregulates intestinal expression of indoleamine 2,3-dioxygenase 1 (IDO1), the rate-limiting enzyme of the KP, while microbiota restoration reversed this effect. Computational analyses associate Lachnospiraceae and Oscillospiraceae with colonic IDO1 in mice and inflammatory bowel disease cohorts. In vitro experiments support a mechanism whereby microbiota perturbation alters host absorption of the vitamin E isoform, γ-tocotrienol, which impacts IDO1 expression. Our findings support that the gut microbiota controls colonic KP through micronutrient absorption.

28 September 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
JSJonas Schluter
Jonas Schluter
ADAna Djukovic
Ana Djukovic
BTBradford P. Taylor
Bradford P. Taylor
JYJinyuan Yan
Jinyuan Yan
CDCaichen Duan
Caichen Duan
JXJoao B. Xavier
Joao B. Xavier
SUMMARY: The microbiome is associated with health and disease, but causal effects are hard to quantify— especially in humans where controlled experiments are nearly impossible. Akin to natural experiments, closely monitored patients offer an alternative to characterize microbiome effects. We present TaxUMAP, a taxonomically-informed visualization method to effectively display diverse microbiome states. TaxUMAP charts a microbiome atlas from 1,870 cancer patients as they progress through therapy-induced perturbations, and quantifies the microbiome contribution to patients’ risk for life-threatening bacteremia. We find that the lowest diversity states (gut dominations) that follow antibiotic treatments are stable, and that diverse communities harbor more diverse antimicrobial resistance genes than dominations. We reveal that certain Klebsiella species are associated with reduced risk for bacteremia, an effect driven by bacterial competition that we validate experimentally in vitro and in vivo . TaxUMAP effectively maps longitudinal microbiome data that can facilitate research into causal microbiome effects on human health. HIGHLIGHTS: TaxUMAP charts an atlas of patients’ microbiome states and their clinical context to reveal new causal effects. Antibiotics deplete the biodiversity and reduce the number of different antimicrobial resistance genes in the gut microbiome. Certain Klebsiella species are associated with lower risk of bacteremia by other gut-borne pathogens. These Klebsiella outcompete other gram-negative pathogens in vivo .

19 June 2026 in Nature Microbiology
Verified
Journal Article
Closed access
PDF file
LRLavinia Renzi
Lavinia Renzi
ADAna Djukovic
Ana Djukovic